Humasis Co. Ltd (205470) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.036x

Based on the latest financial reports, Humasis Co. Ltd (205470) has a cash flow conversion efficiency ratio of 0.036x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩8.98 Billion ≈ $6.08 Million USD) by net assets (₩248.94 Billion ≈ $168.71 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Humasis Co. Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Humasis Co. Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Humasis Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Humasis Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Humasis Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
RADCOM Ltd F:RAM	N/A
Axiom Intelligence Acquisition Corp 1 Class A Ordinary Shares NASDAQ:AXIN	-0.001x
Gyldendal A/S CO:GYLD-A	0.262x
Utah Medical Products Inc NASDAQ:UTMD	0.026x
Nasmed Ozel Saglik Hizmetleri Ticaret AS IS:EGEPO	0.093x
Boyaa Interactive International Limited F:1BY	0.002x
Midsona AB (publ) ST:MSON-B	0.016x
Ohio Valley Banc Corp NASDAQ:OVBC	0.045x

Annual Cash Flow Conversion Efficiency for Humasis Co. Ltd (2016–2024)

The table below shows the annual cash flow conversion efficiency of Humasis Co. Ltd from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see Humasis Co. Ltd stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩229.26 Billion ≈ $155.37 Million	₩30.37 Billion ≈ $20.58 Million	0.132x	+168.60%
2023-12-31	₩287.33 Billion ≈ $194.72 Million	₩-55.48 Billion ≈ $-37.60 Million	-0.193x	-133.05%
2022-12-31	₩346.73 Billion ≈ $234.98 Million	₩202.60 Billion ≈ $137.30 Million	0.584x	-42.43%
2021-12-31	₩202.01 Billion ≈ $136.90 Million	₩205.02 Billion ≈ $138.94 Million	1.015x	+246.69%
2020-12-31	₩48.84 Billion ≈ $33.10 Million	₩14.30 Billion ≈ $9.69 Million	0.293x	+472.45%
2019-12-31	₩15.24 Billion ≈ $10.33 Million	₩779.58 Million ≈ $528.31K	0.051x	+210.38%
2018-12-31	₩16.13 Billion ≈ $10.93 Million	₩-747.08 Million ≈ $-506.29K	-0.046x	+75.66%
2017-12-31	₩15.60 Billion ≈ $10.57 Million	₩-2.97 Billion ≈ $-2.01 Million	-0.190x	-1468.41%
2016-12-31	₩10.86 Billion ≈ $7.36 Million	₩151.11 Million ≈ $102.40K	0.014x	--

About Humasis Co. Ltd

KQ:205470 Korea Medical Devices

Market Cap

$213.18 Million

₩314.57 Billion KRW

Market Cap Rank

#16398 Global

#597 in Korea

Share Price

₩2780.00

Change (1 day)

-0.71%

52-Week Range

₩682.00 - ₩4265.00

All Time High

₩8520.77